Adela is focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test. The Company’s genome-wide methylation analysis technology has the unique ability to distinguish the most-highly informative (methylated) regions of the genome from the non-informative regions and preferentially target those informative regions for sequencing. The technology is initially being developed for use across the cancer continuum for detection, diagnosis, and management, and in the future will be applied to other conditions beyond cancer.
The Executive Assistant (EA) will provide advanced administrative support to ensure the smooth operations of the CEO and Senior Leadership Team. The EA will be extremely well organized, an excellent communicator, capable of effectively managing complex schedules, skilled at interfacing with key external audiences, and able to prioritize and work closely with other members of the executive team to coordinate various activities. Over time, the EA will be able to anticipate many of the needs of the team and will be proactive in the execution of those needs.